Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease

被引:83
作者
Kaminski, Tomasz W. [1 ]
Pawlak, Krystyna [2 ]
Karbowska, Malgorzata [1 ]
Mysliwiec, Michal [3 ]
Pawlak, Dariusz [1 ]
机构
[1] Med Univ Bialystok, Dept Pharmacodynam, Mickiewicza 2C Str, PL-15222 Bialystok, Poland
[2] Med Univ Bialystok, Dept Monitored Pharmacotherapy, Mickiewicza 2C Str, PL-15089 Bialystok, Poland
[3] Med Univ Bialystok, Dept Nephrol & Clin Transplantat, Zurawia 14 Str, PL-15540 Bialystok, Poland
关键词
Indoxyl sulfate; Hemostatic disorder; Prothrombotic state; Chronic kidney disease; Monocytes activation; Uremic toxin; Tryptophan derivatives; Tissue factor; von Willebrand factor; Cardiovascular disease; ARYL-HYDROCARBON RECEPTOR; ENDOTHELIAL-CELLS; RISK-FACTORS; KYNURENINE PATHWAY; OXIDATIVE STRESS; ACTIVATION; EXPRESSION; MORTALITY; DYSFUNCTION; TARGET;
D O I
10.1186/s12882-017-0457-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: During chronic kidney disease progression, kidney-specific risk factors for cardiovascular disease come into play. The present study investigated the impact of indoxyl sulfate, dietary tryptophan-derived uremic toxin, accumulated in the blood of patients with chronic kidney disease on hemostatic parameters, markers of inflammation, oxidative stress and monocyte to macrophage transition. Methods: Fifty-one CKD patients not undergoing hemodialysis were enrolled in the study. Coagulation factors, fibrinolytic parameters, adhesion molecules, endothelial dysfunction markers, oxidative stress as well as inflammation markers were examined using immune-enzymatic method. Indoxyl sulfate levels were assessed using high-performance liquid chromatography. Biochemical parameters were determined by routine laboratory techniques using an automated analyzers. All assessed parameters were compared with controls and subjected to cross-sectional statistical analysis. Results: Elevated concentrations of indoxyl sulfate, the vast majority of parameters affecting hemostasis, and markers of renal insufficiency conditions were observed. Part of hemostatic factors, namely tissue factor, von Willebrand factor, thrombomodulin, soluble urokinase-type plasminogen activator receptor, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion protein were correlated with the fraction of indoxyl sulfate. A significant quantity of assessed parameters showed strong correlations with superoxide-dismutase, renal insufficiency rate, C-reactive protein, and neopterin. Levels of indoxyl sulfate were independently associated with markers of impaired endothelial function (thrombomodulin, adhesion molecules), oxidative stress (superoxide-dismutase) and monocytes activation determinant (neopterin), which indicate unconventional links between these systems and the role of indoxyl sulfate. Furthermore, parameters that correlated with the levels of indoxyl sulfate (von Willebrand factor, soluble urokinase-type plasminogen activator receptor, soluble intercellular adhesion molecule-1) were positively associated with the prevalence of cardiovascular disease in a CKD patients. Conclusions: The study demonstrated that in conditions of chronic exposure to uremic toxins, indoxyl sulfate seems to be one of the "missing links" between impaired renal function and prevalence of cardiovascular events, especially hemostatic disorders. The main functions of the action appear to be altered monocytes activation, intensified inflammatory process, and augmented oxidative stress by this uremic toxin.
引用
收藏
页数:12
相关论文
共 52 条
  • [1] HPLC-Fluorescence Method for Measurement of the Uremic Toxin Indoxyl Sulfate in Plasma
    Al Za'abi, Mohammed
    Ali, Badreldin
    Al Toubi, Mohammed
    [J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2013, 51 (01) : 40 - 43
  • [2] Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients
    Avci, Emre
    Coskun, Sule
    Cakir, Erdinc
    Kurt, Yasemin
    Akgul, Emin Ozgur
    Bilgi, Cumhur
    [J]. RENAL FAILURE, 2008, 30 (08) : 784 - 790
  • [3] Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages
    Barisione, Chiara
    Garibaldi, Silvano
    Furfaro, Anna Lisa
    Nitti, Mariapaola
    Palmieri, Daniela
    Passalacqua, Mario
    Garuti, Anna
    Verzola, Daniela
    Parodi, Alessia
    Ameri, Pietro
    Altieri, Paola
    Fabbi, Patrizia
    Ferrar, Pier Francesco
    Brunelli, Claudio
    Arsenescu, Violeta
    Balbi, Manrico
    Palombo, Domenico
    Ghigliotti, Giorgio
    [J]. PLOS ONE, 2016, 11 (02):
  • [4] Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
    Barisione, Chiara
    Ghigliotti, Giorgio
    Canepa, Marco
    Balbi, Manrico
    Brunelli, Claudio
    Ameri, Pietro
    [J]. CURRENT DRUG TARGETS, 2015, 16 (04) : 366 - 372
  • [5] Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
    Barreto, Fellype C.
    Barreto, Daniela V.
    Liabeuf, Sophie
    Meert, Natalie
    Glorieux, Griet
    Temmar, Mohammed
    Choukroun, Gabriel
    Vanholder, Raymond
    Massy, Ziad A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (10): : 1551 - 1558
  • [6] Basu Gopal, 2012, Indian J Endocrinol Metab, V16, P204, DOI 10.4103/2230-8210.93737
  • [7] Release of soluble urokinase receptor from vascular cells
    Chavakis, T
    Willuweit, AK
    Lupu, F
    Preissner, KT
    Kanse, SM
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 686 - 693
  • [8] Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease
    Chen, Jing
    Hamm, L. Lee
    Mohler, Emile R.
    Hudaihed, Alhakam
    Arora, Robin
    Chen, Chung-Shiuan
    Liu, Yanxi
    Browne, Grace
    Mills, Katherine T.
    Kleinpeter, Myra A.
    Simon, Eric E.
    Rifai, Nader
    Klag, Michael J.
    He, Jiang
    [J]. PLOS ONE, 2015, 10 (07):
  • [9] Carvedilol inhibits tumor necrosis factor-α-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells
    Chen, JW
    Lin, FY
    Chen, YH
    Wu, TC
    Chen, YL
    Lin, SJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) : 2075 - 2081
  • [10] Chitalia VC, 2013, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.112, DOI 10.1161/CIRCULATIONAHA.112]